141 related articles for article (PubMed ID: 19619122)
41. Encapsulation of superparamagnetic iron oxide nanoparticles in poly-(lactide-co-glycolic acid) microspheres for biomedical applications.
Gun S; Edirisinghe M; Stride E
Mater Sci Eng C Mater Biol Appl; 2013 Aug; 33(6):3129-37. PubMed ID: 23706192
[TBL] [Abstract][Full Text] [Related]
42. One-step electrohydrodynamic production of drug-loaded micro- and nanoparticles.
Enayati M; Ahmad Z; Stride E; Edirisinghe M
J R Soc Interface; 2010 Apr; 7(45):667-75. PubMed ID: 19828501
[TBL] [Abstract][Full Text] [Related]
43. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
44. Polymeric nanoparticles - Influence of the glass transition temperature on drug release.
Lappe S; Mulac D; Langer K
Int J Pharm; 2017 Jan; 517(1-2):338-347. PubMed ID: 27986475
[TBL] [Abstract][Full Text] [Related]
45. Dexamethasone acetate encapsulation into Trojan particles.
Gómez-Gaete C; Fattal E; Silva L; Besnard M; Tsapis N
J Control Release; 2008 May; 128(1):41-9. PubMed ID: 18374442
[TBL] [Abstract][Full Text] [Related]
46. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).
Cruz J; Flórez J; Torres R; Urquiza M; Gutiérrez JA; Guzmán F; Ortiz CC
Nanotechnology; 2017 Mar; 28(13):135102. PubMed ID: 28266350
[TBL] [Abstract][Full Text] [Related]
48. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
49. Surface functionality as a means to impact polymer nanoparticle size and structure.
Schneider J; Jallouk AP; Vasquez D; Thomann R; Forget A; Pino CJ; Shastri VP
Langmuir; 2013 Mar; 29(12):4092-5. PubMed ID: 23438034
[TBL] [Abstract][Full Text] [Related]
50. Determining dominant driving forces affecting controlled protein release from polymeric nanoparticles.
Smith J; Sprenger KG; Liao R; Joseph A; Nance E; Pfaendtner J
Biointerphases; 2017 May; 12(2):02D412. PubMed ID: 28525957
[TBL] [Abstract][Full Text] [Related]
51. Liquid jet breakup: A new method for the preparation of poly lactic-co-glycolic acid microspheres.
Xia Y; Yuan M; Chen M; Li J; Ci T; Ke X
Eur J Pharm Biopharm; 2019 Apr; 137():140-147. PubMed ID: 30818010
[TBL] [Abstract][Full Text] [Related]
52. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
[TBL] [Abstract][Full Text] [Related]
53. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.
Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y
J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715
[TBL] [Abstract][Full Text] [Related]
54. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
Mosafer J; Teymouri M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
[TBL] [Abstract][Full Text] [Related]
55. Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide.
Bahari Javan N; Montazeri H; Rezaie Shirmard L; Jafary Omid N; Barbari GR; Amini M; Ghahremani MH; Rafiee-Tehrani M; Abedin Dorkoosh F
Eur J Pharm Sci; 2017 Apr; 101():167-181. PubMed ID: 28193537
[TBL] [Abstract][Full Text] [Related]
56. Poly (lactic-co-glycolic acid) particles prepared by microfluidics and conventional methods. Modulated particle size and rheology.
Perez A; Hernández R; Velasco D; Voicu D; Mijangos C
J Colloid Interface Sci; 2015 Mar; 441():90-7. PubMed ID: 25490568
[TBL] [Abstract][Full Text] [Related]
57. Following the concentration of polymeric nanoparticles during nebulization.
Beck-Broichsitter M; Knuedeler MC; Schmehl T; Seeger W
Pharm Res; 2013 Jan; 30(1):16-24. PubMed ID: 22806406
[TBL] [Abstract][Full Text] [Related]
58. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
59. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
60. Characterization of PLGA microparticles as a drug carrier for 3-ethoxycarbonyl-2h-benzofuro[3,2-f]-1-benzopyran-2-one. Ultrastructural study of cellular uptake and intracellular distribution.
Gomes AJ; Faustino AS; Machado AE; Zaniquelli ME; de Paula Rigoletto T; Lunardi CN; Lunardi LO
Drug Deliv; 2006; 13(6):447-54. PubMed ID: 17002973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
